This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Ex Vivo Induction of mRNA in Human Whole Blood as a New Platform of Drug and Dietary Supplement Development
Pharmaceutical Research Open Access 09 January 2008
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Waga, S., Hannon, G. J., Beach, D. & Stillman, B. Nature 369, 574–578 (1994).
Nobori, T. et al. Nature 368, 753–756 (1994).
Kamb, A. et al. Science 264, 436–440 (1994).
Xiong, Y., Zhang, H. & Beach, D. Genes Dev. 7, 1572–1583 (1993).
Hunter, T. Cell 75, 839–841 (1993).
Dulić, V. et al. Cell 76, 1013–1023 (1994).
Nugroho, T. T. & Mendenhall, M. D. Molec. cell. Biol. 14, 3320–3328 (1994).
Moreno, S. & Nurse, P. Nature 367, 236–242 (1994).
Axton, J. M. et al. EMBO J. 13, 462–470 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pines, J. p21 inhibits cyclin shock. Nature 369, 520–521 (1994). https://doi.org/10.1038/369520a0
Issue Date:
DOI: https://doi.org/10.1038/369520a0
This article is cited by
-
Ex Vivo Induction of mRNA in Human Whole Blood as a New Platform of Drug and Dietary Supplement Development
Pharmaceutical Research (2008)
-
Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer
Oncogene (2004)
-
Curable and noncurable malignancies:Lessons from paediatric cancer
Medical Oncology (1996)
-
Regulation of apoptosis in immune cells
Journal of Clinical Immunology (1995)